11 results
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
events TZDs DPP ... Improved outcomes in CKD ... medications #table #comparison ... endocrinology #dm2
Diabetes Type 2 Medication Management and Titration Algorithm
- First line therapy is metformin and comprehensive lifestyle
and Titration Algorithm ... Established ASCVD or CKD ... established ASCVD or CKD ... #Diabetes #DM2 ... Medication #Management #Algorithm
Patient factors influencing the selection Of glucose-lowering drugs Other than SGLT2i and metformin in T2D and
metformin in T2D and CKD ... kidney disease, DPP4i ... , #KDIGO2020 #CKD ... Management in CKD ... management #treatment #CHART
Causes of Polyneuropathy - Differential Diagnosis Algorithm
 • Metabolic: DM, Hypothyroidism, CKD, Cirrhosis, Nutritional deficiency
 •
Differential Diagnosis Algorithm ... • Metabolic: DM ... Hypothyroidism, CKD ... Paraneoplastic, CTD ... Differential #Diagnosis #Algorithm
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Sulfonylurea, TZD, DPP ... Diabetes #Mellitus #DM2 ... #pharmacology #comparison
Idiopathic Inflammatory Myopathies - 
Dermatomyositis (DM), Immune-Mediated Necrotizing Myopathy (IMNM), Antisynthetase Syndrome (ASS), Inclusion Body Myositis
Dermatomyositis (DM ... Idiopathic #Myopathy #Comparison ... #Managment #algorithm
Secondary Causes of Hypertension - Differential Diagnosis Algorithm
Hypertension - BP > 140/90 (>130/80 for DM)
Hypertensive urgency
Differential Diagnosis Algorithm ... 90 (>130/80 for DM ... end-organ damage or DM ... syndrome • AKI/CKD ... Differential #Diagnosis #Algorithm
Causes of Chronic Kidney Disease - Differential Diagnosis Algorithm
Decreased kidney function (eGFR < 60 ml/min/1.73 m2)
Differential Diagnosis Algorithm ... 60 ml/min/1.73 m2 ... Hyperphosphatemia #CKD ... Differential #Diagnosis #Algorithm
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
angiotensin-receptor blocker; CAD ... resynchronization therapy; DM ... Stages #ACCAHA #Algorithm
Algorithm for Diagnosis and Management of Resistant Hypertension in CKD
Pseudoresistant Hypertension - Reduce barriers to adherence:
Algorithm for Diagnosis ... Hypertension in CKD ... Evaluate for CKD ... 30 mL/min/1.73 m2 ... #Algorithm #Diagnosis